Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the production of advanced fuels and chemicals through the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into advanced Biorefineries.
Founded in 2006, Aemetis owns and operates a 60 million gallon per year capacity ethanol and animal feed production facility in Keyes, California. Aemetis also owns and operates a 50 million gallon per year capacity renewable chemical and advanced fuel production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds nine granted patents on technology related to the production of renewable fuels and renewable chemicals.
In 2014, Aemetis revenues were $208 million. The company has over 130 employees worldwide, and is publically traded on the NASDAQ stock market under the symbol AMTX.
Derived from the Scottish “Ae,” meaning “the one” and the Greek “Metis,” meaning “prudent wisdom,” Aemetis means “the one prudent wisdom,” referring to the prudence and wisdom of replacing petroleum with renewable chemicals and fuels.